The Story of Influenza Antivirals: Part 24. Tamiflu and neuropsychiatric adverse events

Why access to regulatory data rather than published articles is essential and why asking pharma if their products cause problems is like asking a fox to guard the henhouse.

A controversial issue with use of Tamiflu was whether it could cause neuropsychiatric adverse events. Prior to the 2009 influenza pandemic, most Tamiflu usage occurred in Japan. Reports of accidental…